EVT 201

Phase 2Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Sleep Initiation and Maintenance Disorders

Conditions

Sleep Initiation and Maintenance Disorders

Trial Timeline

Sep 1, 2006 → Apr 1, 2007

About EVT 201

EVT 201 is a phase 2 stage product being developed by Evotec for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00380003. Target conditions include Sleep Initiation and Maintenance Disorders.

What happened to similar drugs?

20 of 20 similar drugs in Sleep Initiation and Maintenance Disorders were approved

Approved (20) Terminated (2) Active (0)
Zolpidem MR + EstazolamAstellas PharmaApproved
Zolpidem MR + Zolpidem IRAstellas PharmaApproved
Lemborexant + PlaceboEisaiApproved
Eszopiclone + Placebo controlSumitomo PharmaApproved
Eszopiclone + Fluoxetine + PlaceboSumitomo PharmaApproved
Lunesta + Placebo controlSumitomo PharmaApproved
LunestaSumitomo PharmaApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00401284Phase 2Completed
NCT00380003Phase 2Completed

Competing Products

20 competing products in Sleep Initiation and Maintenance Disorders

See all competitors